Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 44th Annual Healthcare Conference on Monday, January 12, 2026. The company’s presentation and participation in a fireside chat will begin at 7:30 a.m. PST/10:30 a.m. ET. The event will be webcast simultaneously at http://investor.bms.com, with materials related to … [Read more…]

Frédéric Prince to Succeed Christian Loss, Effective January 1st, 2026

RAPPERSWIL, Switzerland–(BUSINESS WIRE)–Dr. Christian Loss, Chief Executive Officer (CEO) of Neovii Pharmaceuticals AG, will take a well-deserved retirement after his distinguished career at Neovii. As of January, he is succeeded by Frédéric Prince PhD, who most recently served as Head of Strategy and Chief of Staff ad interim to the Head of Oncology in Roche’s … [Read more…]

AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “AtriCure Inc (ATRC) – Product Pipeline Analysis, 2025 Update” company profile has been added to ResearchAndMarkets.com’s offering. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. AtriCure Inc (AtriCure) is a … [Read more…]

Cell & Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cell & Gene Therapies in Respiratory Disorders: Therapeutic Analysis” report has been added to ResearchAndMarkets.com’s offering. The cell and gene therapies (CGTs) landscape for respiratory diseases is currently in the early stages of development, with no marketed CGTs to date. Reasons to Buy Develop and design your in-licensing and out-licensing strategies through a … [Read more…]

7MM Diabetic Macular Edema (DME) Epidemiology Forecast Report 2024-2034: Focus on US, France, Germany, Italy, Spain, UK, and Japan – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Diabetic Macular Edema (DME): Epidemiology Forecast to 2034” report has been added to ResearchAndMarkets.com’s offering. In the 7MM, the diagnosed prevalent cases of DME in diabetes are expected to increase from 2,888,125 cases in 2024 to 3,463,149 cases in 2034, at an annual growth rate (AGR) of 1.99%. In 2034, the US will … [Read more…]

Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Sysmex Corp (6869) – Product Pipeline Analysis, 2025 Update” company profile has been added to ResearchAndMarkets.com’s offering. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. Sysmex Corp (Sysmex) is a … [Read more…]

NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference at 3:00pm PT on Wednesday, January 14, 2026, in San Francisco, CA. Management will also host investor meetings … [Read more…]

SBC Medical Announces Capital Strategy: Effectiveness of Form S-3 Registration Statement and Approval of Up to $20 Million Share Repurchase Program

IRVINE, Calif.–(BUSINESS WIRE)–#Healthcare–SBC Medical Group Holdings Incorporated (NASDAQ: SBC) (the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced an updated capital strategy for future growth, which includes the filing of a Form S-3 registration statement with the U.S. Securities and Exchange Commission (SEC) and … [Read more…]

Fu Pai Ejiao Certified as the World’s Oldest Ejiao Brand by Lawrence World Records

JINAN, China–(BUSINESS WIRE)–On the Winter Solstice of December 21, 2025, in Dong’e Town, Shandong — the recognized birthplace of Ejiao — the awarding of a world record was seamlessly woven into an ancient annual ceremony. Mr. Aurelian Constantin, Certification Officer of Lawrence World Records, took to the stage to officially announce that Fu Pai Ejiao … [Read more…]

Promesa y Esperanza® Broadcast Rallies Hispanic Media, Artists, and Fans to Support St. Jude Children’s Research Hospital

Nationwide Event Raises $5.2 Million for St. Jude families MEMPHIS, Tenn.–(BUSINESS WIRE)–The St. Jude Promesa y Esperanza® (Promise and Hope) broadcast earlier this month brought together Hispanic media leaders, Latin music artists, and Spanish-speaking audiences to support research and treatment at St. Jude Children’s Research Hospital®. The event, part of the Music Gives to St. … [Read more…]